Edition:
United Kingdom

NanoVibronix Inc (NAOV.OQ)

NAOV.OQ on NASDAQ Stock Exchange Capital Market

4.60USD
15 Feb 2018
Change (% chg)

-- (--)
Prev Close
$4.60
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
--
52-wk High
$4.90
52-wk Low
$3.68

Latest Key Developments (Source: Significant Developments)

Nanovibronix Inc - Signed Morulaa Healthtech As Its Regulatory And Marketing Partner In India
Wednesday, 20 Dec 2017 

Dec 20 (Reuters) - Nanovibronix Inc ::NANOVIBRONIX INC - SIGNED MORULAA HEALTHTECH AS ITS REGULATORY AND MARKETING PARTNER IN INDIA.  Full Article

Nanovibronix Announces Exclusive U.K. Distributor For Painshield
Tuesday, 5 Dec 2017 

Dec 5 (Reuters) - Nanovibronix Inc ::NANOVIBRONIX ANNOUNCES EXCLUSIVE UK DISTRIBUTOR FOR PAINSHIELD(TM) PROVIDING PATIENTS AN ALTERNATIVE TO OPIOIDS AND SURGERY.SAYS ‍IT HAS SIGNED BHR PHARMACEUTICALS LTD AS ITS EXCLUSIVE DISTRIBUTOR FOR PAINSHIELD IN UNITED KINGDOM​.  Full Article

Nanovibronix ‍Expects To Complete Trial For Use Of Painshield In Patients With Trigeminal Neuralgia In Q1 Of 2018​
Wednesday, 29 Nov 2017 

Nov 29 (Reuters) - Nanovibronix Inc ::NANOVIBRONIX REPORTS SUCCESSFUL INTERIM TRIAL RESULTS FOR USE OF PAINSHIELD(TM) IN PATIENTS WITH TRIGEMINAL NEURALGIA; REPRESENTS POTENTIAL ALTERNATIVE TO OPIOID AND SURGICAL INTERVENTIONS.NANOVIBRONIX INC - ‍EXPECTS TO COMPLETE TRIAL FOR USE OF PAINSHIELD IN PATIENTS WITH TRIGEMINAL NEURALGIA IN Q1 OF 2018​.  Full Article

Nanovibronix Inc to commence trial of anti-aging device
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - Nanovibronix Inc :Nanovibronix to commence trial of anti-aging device in collaboration with a global cosmetics company.Execution of collaborative agreement to conduct a single-center clinical trial in conjunction with a global cosmetics company​.Following trial, the two companies plan to explore further collaboration opportunities​.  Full Article

BRIEF-Nanovibronix Inc - Signed Morulaa Healthtech As Its Regulatory And Marketing Partner In India

* NANOVIBRONIX INC - SIGNED MORULAA HEALTHTECH AS ITS REGULATORY AND MARKETING PARTNER IN INDIA Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)